SARS-CoV-2 invasion of the central nervous: a brief review

Hosp Pract (1995). 2021 Aug;49(3):157-163. doi: 10.1080/21548331.2021.1887677. Epub 2021 Mar 1.

Abstract

There is increasing evidence of the ability of the novel coronavirus to invade the central nervous system (CNS). But how does a respiratory virus invade the highly protected CNS? Here, we reviewed available literature and case reports to determine CNS involvement in COVID-19, and to identify potential regions of the brain that may be affected by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and its possible route of entry into the brain to identify its pathogenicity. Based on the symptoms, the parietal lobe and the cerebellum are the likely targets of SARS-CoV-2; however, further work is needed to elucidate this. The presence of ACE2, used by SARS-CoV-2 for cell entry, in the brain as well as detection of the virus in the cerebrospinal fluid, further assert that SARS-COV-2 targets the brain, and therefore, medical practitioners should take that into account when dealing with patients suffering from COVID-19.

Keywords: 2019-nCoV; COVID-19; SARS-CoV-2; brain; central nervous system; coronavirus; encephalitis.

Publication types

  • Review

MeSH terms

  • Blood-Brain Barrier / pathology
  • Blood-Brain Barrier / virology*
  • Brain / virology
  • COVID-19 / pathology
  • COVID-19 / virology*
  • Central Nervous System / pathology
  • Central Nervous System / virology*
  • Cerebrospinal Fluid / virology
  • Humans
  • SARS-CoV-2 / pathogenicity*